Spots Global Cancer Trial Database for hydrocortisone sodium succinate

Every month we try and update this database with for hydrocortisone sodium succinate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
A Study of SNDX-5613 in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia	NCT05761171	Recurrent Acute... Recurrent Acute... Recurrent Acute... Recurrent Acute... Recurrent Acute... Recurrent Mixed... Refractory Acut... Refractory Acut... Refractory Acut... Refractory Acut... Refractory Acut... Refractory Mixe...	Biospecimen Col... Bone Marrow Asp... Calaspargase Pe... Cytarabine Echocardiograph... Fludarabine Pho... Hydrocortisone ... Lumbar Puncture Methotrexate Multigated Acqu... Prednisolone Prednisone Revumenib Vincristine Sul...	1 Month - 6 Years	Children's Oncology Group
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations	NCT02883049	B Acute Lymphob... B Acute Lymphob... Central Nervous... Testicular Leuk...	Clofarabine Cyclophosphamid... Cytarabine Dasatinib Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Etoposide Hydrocortisone ... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul...	1 Year - 31 Years	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations	NCT02883049	B Acute Lymphob... B Acute Lymphob... Central Nervous... Testicular Leuk...	Clofarabine Cyclophosphamid... Cytarabine Dasatinib Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Etoposide Hydrocortisone ... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul...	1 Year - 31 Years	National Cancer Institute (NCI)
ALL Adult Consortium Trial: Adult ALL Trial	NCT00476190	Acute Lymphobla...	Doxorubicin Cytarabine Methotrexate Vincristine Cyclophosphamid... Methylprednison... Hydrocortisone ... Dexamethasone 6-MP PEG-Asparaginas... Imatinib Etoposide Radiation Thera... E. coli Asparag...	18 Years - 50 Years	Dana-Farber Cancer Institute
A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat	NCT05320380	Recurrent Acute... Recurrent B Acu... Recurrent Mixed... Recurrent T Acu... Refractory Acut... Refractory B Ac... Refractory Mixe... Refractory T Ac...	Anti-CD123 ADC ... Bone Marrow Asp... Cytarabine Fludarabine Pho... Hydrocortisone ... Liposome-encaps... Methotrexate Prednisolone	12 Months - 22 Years	Children's Oncology Group
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement	NCT02828358	Acute Leukemia ... B Acute Lymphob... Mixed Phenotype...	Azacitidine Cyclophosphamid... Cytarabine Daunorubicin Daunorubicin Hy... Dexamethasone Hydrocortisone ... Laboratory Biom... Leucovorin Leucovorin Calc... Mercaptopurine Methotrexate Pegaspargase Pharmacological... Prednisolone Thioguanine Vincristine Vincristine Sul...	- 364 Days	National Cancer Institute (NCI)
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00720109	Acute Lymphobla... Adult B Acute L... Childhood B Acu...	Asparaginase Cyclophosphamid... Cytarabine Dasatinib Daunorubicin Hy... Dexamethasone Etoposide Filgrastim Hydrocortisone ... Ifosfamide Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Methylprednisol... Pegaspargase Prednisone Radiation Thera... Vincristine Sul...	2 Years - 30 Years	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT01005758	Leukemia	cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide phosp... hydrocortisone ... imatinib mesyla... mercaptopurine methotrexate methylprednisol... pegaspargase prednisolone prednisone vincristine sul... laboratory biom... radiation thera...	18 Years - 50 Years	National Cancer Institute (NCI)
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)	NCT04546399	Down Syndrome Recurrent B Acu...	3-Dimensional C... Blinatumomab Cyclophosphamid... Cytarabine Dexamethasone Etoposide Hydrocortisone ... Leucovorin Calc... Mercaptopurine Methotrexate Nivolumab Pegaspargase Thioguanine Vincristine Sul...	1 Year - 30 Years	National Cancer Institute (NCI)
A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat	NCT05320380	Recurrent Acute... Recurrent B Acu... Recurrent Mixed... Recurrent T Acu... Refractory Acut... Refractory B Ac... Refractory Mixe... Refractory T Ac...	Anti-CD123 ADC ... Bone Marrow Asp... Cytarabine Fludarabine Pho... Hydrocortisone ... Liposome-encaps... Methotrexate Prednisolone	12 Months - 22 Years	Children's Oncology Group
ALL Adult Consortium Trial: Adult ALL Trial	NCT00476190	Acute Lymphobla...	Doxorubicin Cytarabine Methotrexate Vincristine Cyclophosphamid... Methylprednison... Hydrocortisone ... Dexamethasone 6-MP PEG-Asparaginas... Imatinib Etoposide Radiation Thera... E. coli Asparag...	18 Years - 50 Years	Dana-Farber Cancer Institute
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT01005758	Leukemia	cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide phosp... hydrocortisone ... imatinib mesyla... mercaptopurine methotrexate methylprednisol... pegaspargase prednisolone prednisone vincristine sul... laboratory biom... radiation thera...	18 Years - 50 Years	National Cancer Institute (NCI)
Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma	NCT00057811	Childhood Burki... Childhood Diffu... Childhood Immun... Stage I Childho... Stage I Childho... Stage II Childh... Stage II Childh... Stage III Child... Stage III Child... Stage IV Childh... Stage IV Childh... Untreated Child...	doxorubicin hyd... cyclophosphamid... methotrexate rasburicase leucovorin calc... prednisone methylprednisol... filgrastim rituximab cytarabine etoposide vincristine sul... hydrocortisone ... laboratory biom...	1 Year - 29 Years	Children's Oncology Group
A Study of SNDX-5613 in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia	NCT05761171	Recurrent Acute... Recurrent Acute... Recurrent Acute... Recurrent Acute... Recurrent Acute... Recurrent Mixed... Refractory Acut... Refractory Acut... Refractory Acut... Refractory Acut... Refractory Acut... Refractory Mixe...	Biospecimen Col... Bone Marrow Asp... Calaspargase Pe... Cytarabine Echocardiograph... Fludarabine Pho... Hydrocortisone ... Lumbar Puncture Methotrexate Multigated Acqu... Prednisolone Prednisone Revumenib Vincristine Sul...	1 Month - 6 Years	Children's Oncology Group
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement	NCT02828358	Acute Leukemia ... B Acute Lymphob... Mixed Phenotype...	Azacitidine Cyclophosphamid... Cytarabine Daunorubicin Daunorubicin Hy... Dexamethasone Hydrocortisone ... Laboratory Biom... Leucovorin Leucovorin Calc... Mercaptopurine Methotrexate Pegaspargase Pharmacological... Prednisolone Thioguanine Vincristine Vincristine Sul...	- 364 Days	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: